Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Janoff EN, Rubins JB, Fasching C, Charboneau D, Rahkola JT, Plaut AG, Weiser JN.

Mucosal Immunol. 2014 Mar;7(2):249-56. doi: 10.1038/mi.2013.41. Epub 2013 Jul 3.

2.

Chest pain and progressive miliary infiltrates in an elderly man.

Rubins JB, Solomon R, Colby T, Kelly R.

Chest. 2009 Feb;135(2):578-582. doi: 10.1378/chest.07-3002. No abstract available.

PMID:
19201724
3.

Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians.

Rubins JB, Raci E, Kunisaki KM.

Postgrad Med. 2009 Jan;121(1):104-12. doi: 10.3810/pgm.2009.01.1959. Review.

PMID:
19179818
4.

Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer.

Groth SS, Whitson BA, Kuskowski MA, Holmstrom AM, Rubins JB, Kelly RF.

Lung Cancer. 2009 Jun;64(3):352-7. doi: 10.1016/j.lungcan.2008.09.015. Epub 2008 Nov 18.

PMID:
19019489
5.

Contemporary issues in the diagnosis and treatment of obstructive sleep apnea.

Rubins JB, Kunisaki KM.

Postgrad Med. 2008 Jul;120(2):46-52. doi: 10.3810/pgm.2008.07.1790. Review.

PMID:
18654068
6.

Formoterol fumarate inhalation solution (Perforomist) for COPD.

Rubins JB.

Expert Rev Clin Immunol. 2008 Jul;4(4):415-23. doi: 10.1586/1744666X.4.4.415.

PMID:
20477569
7.

The current approach to the diagnosis of pulmonary embolism: lessons from PIOPED II.

Rubins JB.

Postgrad Med. 2008 Apr;120(1):1-7. doi: 10.3810/pgm.2008.04.1753. Review.

PMID:
18467802
8.

Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.

Nguyen JT, Myers N, Palaia J, Georgopoulos A, Rubins JB, Janoff EN.

Transl Res. 2007 Sep;150(3):172-9. Epub 2007 May 25.

PMID:
17761370
9.

Advanced age does not exclude lobectomy for non-small cell lung carcinoma.

Sullivan V, Tran T, Holmstrom A, Kuskowski M, Koh P, Rubins JB, Kelly RF.

Chest. 2005 Oct;128(4):2671-6.

PMID:
16236941
10.

The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB.

Semin Arthritis Rheum. 2004 Feb;33(4):283-8.

PMID:
14978666
11.
12.

Alveolar macrophages: wielding the double-edged sword of inflammation.

Rubins JB.

Am J Respir Crit Care Med. 2003 Jan 15;167(2):103-4. No abstract available.

PMID:
12524246
13.

Clinical utility of tumor markers in the management of non-small cell lung cancer.

Niewoehner DE, Rubins JB.

Methods Mol Med. 2003;75:135-41. Review. No abstract available.

PMID:
12407738
14.

Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type 1: clinical, immunologic, and virologic responses.

Tasker SA, Wallace MR, Rubins JB, Paxton WB, O'Brien J, Janoff EN.

Clin Infect Dis. 2002 Mar 15;34(6):813-21. Epub 2002 Feb 7.

PMID:
11850863
15.

Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus.

Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, Rubins JB.

Clin Infect Dis. 2002 Jan 15;34(2):147-53. Epub 2001 Dec 4.

PMID:
11740700
16.

Inhibition of mesothelioma cell growth in vitro by doxycycline.

Rubins JB, Charboneau D, Alter MD, Bitterman PB, Kratzke RA.

J Lab Clin Med. 2001 Aug;138(2):101-6.

PMID:
11477376
17.

Pneumococcal disease in the elderly: what is preventing vaccine efficacy?

Rubins JB, Janoff EN.

Drugs Aging. 2001;18(5):305-11. Review.

PMID:
11392439
18.

Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

Zhou JX, Niehans GA, Shar A, Rubins JB, Frizelle SP, Kratzke RA.

Lung Cancer. 2001 Apr;32(1):27-38.

PMID:
11282426
19.

Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus.

Frizelle SP, Rubins JB, Zhou JX, Curiel DT, Kratzke RA.

Cancer Gene Ther. 2000 Nov;7(11):1421-5.

20.

Diagnosis of venous thromboembolism. Step-by-step approach to a still lethal disease.

Rubins JB, Rice K.

Postgrad Med. 2000 Jul;108(1):175-80; quiz 16. Review.

PMID:
10914126
21.

Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial.

Rice KL, Rubins JB, Lebahn F, Parenti CM, Duane PG, Kuskowski M, Joseph AM, Niewoehner DE.

Am J Respir Crit Care Med. 2000 Jul;162(1):174-8.

PMID:
10903238
22.
23.

Translational control of the antiapoptotic function of Ras.

Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC, Bitterman PB.

J Biol Chem. 2000 Aug 11;275(32):24776-80.

24.

Temporal trends in survival after surgical resection of localized non-small cell lung cancer.

Rubins JB, Ewing SL, Leroy S, Humphrey EW, Morrison V.

Lung Cancer. 2000 Apr;28(1):21-7.

PMID:
10704705
25.
26.

Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.

Janoff EN, Fasching C, Orenstein JM, Rubins JB, Opstad NL, Dalmasso AP.

J Clin Invest. 1999 Oct;104(8):1139-47.

27.

Editorial response: Predicting protection against encapsulated pathogens.

Janoff EN, Rubins JB.

Clin Infect Dis. 1999 Aug;29(2):289-91. No abstract available.

PMID:
10476728
28.

Identification of clinical risk factors for nosocomial pneumococcal bacteremia.

Rubins JB, Cheung S, Carson P, Rubins HB, Janoff EN.

Clin Infect Dis. 1999 Jul;29(1):178-83.

PMID:
10433582
29.

Immune activation and virologic response to immunization in recent HIV type 1 seroconverters.

Janoff EN, Tasker SA, Stevenson M, Rubins JB, O'Brien J, Utz G, Weiss P, Hall FW, Wallace MR.

AIDS Res Hum Retroviruses. 1999 Jun 10;15(9):837-45.

PMID:
10381172
30.

Practical management of pleural effusions. When and how should fluid accumulations be drained?

Colice GL, Rubins JB.

Postgrad Med. 1999 Jun;105(7):67-70, 73-7. Review.

PMID:
10376051
31.

Evaluating pleural effusions. How should you go about finding the cause?

Rubins JB, Colice GL.

Postgrad Med. 1999 May 1;105(5):39-42, 45-8. Review.

PMID:
10335319
32.

Pneumolysin in pneumococcal adherence and colonization.

Rubins JB, Paddock AH, Charboneau D, Berry AM, Paton JC, Janoff EN.

Microb Pathog. 1998 Dec;25(6):337-42.

PMID:
9895272
33.

Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer.

Rubins JB, Dunitz J, Rubins HB, Maddaus MA, Niewoehner DE.

J Thorac Cardiovasc Surg. 1998 Sep;116(3):412-6.

34.

Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults.

Rubins JB, Puri AK, Loch J, Charboneau D, MacDonald R, Opstad N, Janoff EN.

J Infect Dis. 1998 Aug;178(2):431-40.

PMID:
9697723
35.

Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.

Alexander JE, Berry AM, Paton JC, Rubins JB, Andrew PW, Mitchell TJ.

Microb Pathog. 1998 Mar;24(3):167-74.

PMID:
9514638
36.

Lovastatin induces apoptosis in malignant mesothelioma cells.

Rubins JB, Greatens T, Kratzke RA, Tan AT, Polunovsky VA, Bitterman P.

Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1616-22.

PMID:
9603146
37.

Do molecular markers predict survival in non-small-cell lung cancer?

Greatens TM, Niehans GA, Rubins JB, Jessurun J, Kratzke RA, Maddaus MA, Niewoehner DE.

Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1093-7.

PMID:
9563724
38.

Prostatic meningeal carcinomatosis presenting as delirium tremens.

Rubins JB, Guzman-Paz MJ.

Postgrad Med J. 1997 Dec;73(866):810-2.

39.

Pneumolysin: a multifunctional pneumococcal virulence factor.

Rubins JB, Janoff EN.

J Lab Clin Med. 1998 Jan;131(1):21-7. Review.

PMID:
9452123
40.

Community-acquired pneumonia. Tailoring management of adult patients according to risk category.

Rubins JB, Janoff EN.

Postgrad Med. 1997 Dec;102(6):45-7, 52, 55-62. Review.

PMID:
9406562
41.

Invasive pneumococcal disease in the immunocompromised host.

Janoff EN, Rubins JB.

Microb Drug Resist. 1997 Fall;3(3):215-32. Review.

PMID:
9270991
42.
43.

Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis.

Ng EW, Samiy N, Rubins JB, Cousins FV, Ruoff KL, Baker AS, D'Amico DJ.

Retina. 1997;17(6):521-9.

PMID:
9428015
44.
45.

Origins of breath nitric oxide in humans.

Dillon WC, Hampl V, Shultz PJ, Rubins JB, Archer SL.

Chest. 1996 Oct;110(4):930-8.

PMID:
8874248
46.

Ethanol ingestion reduces antipneumococcal activity of rat pulmonary surfactant.

Rubins JB, Charboneau D, Prigge W, Mellencamp MA.

J Infect Dis. 1996 Sep;174(3):507-12.

PMID:
8769607
47.

Rb and p16INK4a expression in resected non-small cell lung tumors.

Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA, Geradts J.

Cancer Res. 1996 Aug 1;56(15):3415-20.

48.

Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia.

Rubins JB, Charboneau D, Fasching C, Berry AM, Paton JC, Alexander JE, Andrew PW, Mitchell TJ, Janoff EN.

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1339-46.

PMID:
8616564
49.

Specific and effective interaction of a guanine nucleotide analogue with small G proteins.

Hoffenberg S, Shannon TM, Noonan TP, Liu S, Daniel DS, Fishman JB, Rubins JB, Misra HK, Wright GE, Dickey BF.

Mol Pharmacol. 1996 Jan;49(1):156-64.

PMID:
8569702
50.

Supplemental Content

Loading ...
Support Center